Canada markets open in 9 hours 2 minutes

ImmuCell Corporation (ICCC)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
5.0000-0.0050 (-0.10%)
At close: 04:00PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 38.75M
Enterprise Value 54.47M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)2.22
Price/Book (mrq)1.55
Enterprise Value/Revenue 3.12
Enterprise Value/EBITDA -21.13

Trading Information

Stock Price History

Beta (5Y Monthly) 0.60
52-Week Change 32.04%
S&P500 52-Week Change 321.33%
52 Week High 36.0500
52 Week Low 34.2600
50-Day Moving Average 35.1500
200-Day Moving Average 35.0387

Share Statistics

Avg Vol (3 month) 37.76k
Avg Vol (10 day) 38.21k
Shares Outstanding 57.75M
Implied Shares Outstanding 67.81M
Float 85.6M
% Held by Insiders 127.78%
% Held by Institutions 113.23%
Shares Short (Apr 15, 2024) 44.47k
Short Ratio (Apr 15, 2024) 40.52
Short % of Float (Apr 15, 2024) 40.07%
Short % of Shares Outstanding (Apr 15, 2024) 40.06%
Shares Short (prior month Mar 15, 2024) 46.38k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:100
Last Split Date 3Jul 25, 1990

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -33.05%
Operating Margin (ttm)-9.35%

Management Effectiveness

Return on Assets (ttm)-7.36%
Return on Equity (ttm)-20.86%

Income Statement

Revenue (ttm)17.47M
Revenue Per Share (ttm)2.26
Quarterly Revenue Growth (yoy)30.30%
Gross Profit (ttm)N/A
EBITDA -2.5M
Net Income Avi to Common (ttm)-5.77M
Diluted EPS (ttm)-0.7500
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)978.74k
Total Cash Per Share (mrq)0.13
Total Debt (mrq)16.69M
Total Debt/Equity (mrq)66.78%
Current Ratio (mrq)2.73
Book Value Per Share (mrq)3.22

Cash Flow Statement

Operating Cash Flow (ttm)-4.67M
Levered Free Cash Flow (ttm)-4.51M